1. Cornelius, D. C., Cottrell, J., Amaral, L. M., & LaMarca, B. (2019). Inflammatory mediators: A causal link to hypertension during preeclampsia. British Journal of Pharmacology, 176(12), 1914–1921.
2. Omertayeva, D., Ponamaryova, O., Amirbekova, Z., Vazenmiller, D., & Mugazov, M. (2021). Diagnostic value of determining the level of purine metabolism intermediates in pregnant women with chronic hypertension and superimposed preeclampsia. Journal of Nephropathology, 10(3), 1–6.
3. Enkhmaa, D., Wall, D., Mehta, P. K., Stuart, J. J., Rich-Edwards, J. W., Merz, C. N. B., & Shufelt, C. (2016). Preeclampsia and vascular function: A window to future cardiovascular disease risk. Journal of Women’s Health, 25(3), 284–291.
4. Nawsherwan, A. K., Begum, N., Ahmed, Z., Mubarik, S., Ijaz, U. L. H., Ghulam, N., et al. (2020). Low birth weight, and low ponderal index mediates the association between preeclampsia, placenta previa, and neonatal mortality. Iranian Journal of Public Health, 49(4), 654.
5. Leslie, M. S., & Briggs, L. A. (2016). Preeclampsia and the risk of future vascular disease and mortality: A review. Journal of Midwifery & Women’s Health, 61(3), 315–324.